The National Commission into the Regulation of AI in Healthcare, United Kingdom has delivered a decisive roadmap that recalibrates how artificial intelligence must be governed, through its latest Recommendations for a future regulatory framework
News & Trends
Procurar
Recentes
- PHARMA PACKAGE : Council adopts new rules for a fairer and more competitive EU pharmaceutical sector
- HTA Regulation – Commission selects first medical devices for joint clinical assessment
- PHARMACOVIGILANCE UPDATE | FDA E2B(R3) IMPLEMENTATION GUIDE — OCTOBER 2026
- updated PIC/S PI 006-4 guideline RECOMMENDATIONS ON QUALIFICATION AND VALIDATION
- Annual report of the Pharmacovigilance Inspectors Working Group for 2025
- European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
- ACT EU workplan 2026 – 2027
- Advice on ‘end-of-year’ submission dates for type I variations in 2026